NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Hematology Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hematology Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hemophilia



New hemophilia study results from University of California, Department of Medicine described



April 16th, 2007

Investigators publish new data in the report "Safety and efficacy of TIPS in patients with hemophilia and cirrhosis. The prevalence of portal hypertension and its complications is increasing among patients with hemophilia and cirrhosis. The authors evaluated the safety and efficacy of transjugular intrahepatic postosystemic shunt (TIPS) placement in this population," scientists in the United States report.

"A retrospective analysis was performed of adult patients who underwent TIPS placement at a single center," wrote J.P. Beirne and colleagues, University of California, Department of Medicine.

The researchers concluded: "Four patients with...


Source: Hematology Week (2007-04-16)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login